|

First-time Ablation of Atrial Fibrillation Registry

RECRUITINGSponsored by Medical University of Warsaw
Actively Recruiting
SponsorMedical University of Warsaw
Started2023-12-01
Est. completion2026-03-31
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT06381245

Summary

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia affecting millions globally, with projections indicating a doubling of cases by 2050. AF is linked to heightened cardiovascular risks like stroke and increased healthcare costs. Ablation, targeting the arrhythmia substrate, is a method to manage AF, yet recurrence rates remain high (20-45% in the first year). Studies highlight the impact of comorbidities, AF characteristics, ablation techniques, and myocardial remodeling markers on AF progression and ablation efficacy. However, there's no definitive guidance on selecting these factors for predicting treatment success. The aim of this study is to investigate predictors of successful AF ablation in the following areas: (a) clinical factors, (b) electrophysiological, (c) electrocardiographic, (d) ultrasound, (e) cardiac anatomy, (f) biomarkers.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* paroxysmal or persistent AF
* first-time ablation of AF

Exclusion Criteria:

* patients unable to give informed consent
* serious health condition existing before ablation

Conditions3

ArrhythmiaAtrial FibrillationHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.